Clinical Trials on Inflammatory Breast Cancer in Canada
Total 4508 results
-
Hoffmann-La RocheCompletedBreast CancerCanada, Spain, France, United Kingdom, Italy
-
AstraZenecaCompleted
-
University of CalgaryUniversity Health Network, Toronto; University of British Columbia; Alberta Health... and other collaboratorsRecruitingCancer | Breast Cancer | Head and Neck Cancer | Prostate Cancer | Colon Cancer | Cancer CaregiversCanada
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Ottawa Hospital Research InstituteRecruitingBreast Cancer | Castration-resistant Prostate CancerCanada
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
University Health Network, TorontoMerck Sharp & Dohme LLCActive, not recruitingAdvanced Solid Tumors | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | Malignant Melanoma | Squamous Cell Cancer of Head and NeckCanada
-
Children's Hospital of Eastern OntarioNot yet recruitingInflammatory Bowel Diseases | Crohn DiseaseCanada
-
Ernest SeidmanUniversity of Alberta; University of Toronto; University of CalgaryUnknownCrohn's Disease | Inflammatory Bowel DiseaseCanada
-
University of CyprusRecruitingDepression | Pain | Female Breast CancerCyprus
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Breast Cancer | FGFR2 Amplification | FGFR 1 High AmplificationItaly, United States, France, United Kingdom, Spain, Portugal, Canada
-
McMaster UniversityNot yet recruitingBreast Cancer | Hematoma Postoperative | Tranexamic AcidCanada
-
University of CalgaryTerminated
-
AstraZenecaCompletedNeoplasms | Breast Cancer | Breast NeoplasmsBrazil, Bulgaria, Czech Republic, Peru, Spain, United Kingdom, Sweden, Hungary, Belgium, Canada, Italy, France, Panama, Switzerland
-
AHS Cancer Control AlbertaCross Cancer InstituteTerminated
-
Centre for Addiction and Mental HealthMcMaster UniversityActive, not recruitingInflammatory Bowel Diseases | Major Depressive EpisodeCanada
-
Evelo Biosciences, Inc.Merck Sharp & Dohme LLC; SCRI Development Innovations, LLCCompletedRenal Cell Carcinoma | Non Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | Colorectal Cancer Metastatic | GastroEsophageal Cancer | MSI-HUnited States, Canada
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Peru, Argentina, Chile, Hungary, Mexico, Poland
-
Spanish Breast Cancer Research GroupSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Locally Advanced HER2 Positive Breast CarcinomaSpain
-
PfizerCompletedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
Ottawa Hospital Research InstituteCompletedBreast CancerCanada
-
University of AlbertaCompleted
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term CareCompleted
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Breast Cancer FoundationCompletedQuality of Life | Breast Cancer | Chronic Pain | Painful Neuropathy | Worries; Pain or DisabilityCanada
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast AdenocarcinomaUnited States, Canada
-
McGill University Health Centre/Research Institute...João Pedro Ferreira, MDCompleted
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerUnited States, Canada, United Kingdom, China, Argentina, Australia, Hungary, Netherlands, Korea, Republic of, France, Germany, Italy, Belgium, Bulgaria, India, Mexico, Spain, Vietnam, Colombia, Japan, Peru, Brazil, Malaysia, Taiwan, Tha... and more
-
Ciusss de L'Est de l'Île de MontréalCompletedCervical Cancer | Breast Cancer | Ovarian Cancer | Lung Cancer | Endometrial Cancer | Oesophageal Cancer | Head Cancer NeckCanada
-
Sermonix Pharmaceuticals Inc.RecruitingMetastatic Breast CancerUnited States, France, Belgium, Spain, Israel, Taiwan, United Kingdom, Korea, Republic of, Italy, Australia, Germany, Canada, Czechia, Hungary, Poland, Romania, Singapore, Turkey
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada
-
SOLTI Breast Cancer Research GroupTerminated
-
Fondazione MichelangeloHoffmann-La RocheActive, not recruitingInvasive Breast CancerSpain, Italy, Germany, Austria
-
Hoffmann-La RocheCompletedBreast CancerItaly, Spain, China, Taiwan, Russian Federation, Canada, Germany, Austria, Hungary, Belgium, Australia, Brazil, Mexico, Poland, Panama
-
University of TorontoUniversity Health Network, TorontoCompletedBreast Cancer | Gastrointestinal Cancer | Genitourinary CancerCanada
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Spanish Breast Cancer Research GroupPierre Fabre Laboratories; Puma Biotechnology, Inc.RecruitingHER2 Positive Breast Cancer | Hormone Receptor Positive | Early-stage Breast CancerSpain
-
Byondis B.V.CompletedMetastatic Breast CancerFrance, United States, United Kingdom, Belgium, Spain, Italy, Singapore, Denmark, Sweden, Canada, Netherlands
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsActive, not recruitingHormone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Australia, Puerto Rico, New Zealand, Ireland, Peru, United Kingdom
-
Institut de Recherches Internationales ServierBreast International GroupCompletedBreast CancerUnited Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
-
University of British ColumbiaCanadian Breast Cancer FoundationCompleted
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Nektar TherapeuticsCompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Spain, Korea, Republic of, Canada, United Kingdom, Germany, France, Netherlands, Belgium, Italy, Russian Federation
-
SOLTI Breast Cancer Research GroupNovartis; UNICANCERRecruitingBreast Cancer Stage IISpain, France, Portugal
-
Canadian Cancer Trials GroupPfizerCompleted
-
Advanced Accelerator ApplicationsTerminatedBreast Cancer | Doxorubicin Induced CardiomyopathyCanada
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain